PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS

• Yuqin Song,
• Helen Wu,
• Meng Ji,
• Wenhan Jiang,
• Cassie Dong,
• Jun Zhu

Affiliations

Yuqin Song

1 Peking University Cancer Hospital and Institute,, Beijing, China, Department of Lymphoma, Beijing, China

Helen Wu

2 Takeda Development Center Asian, Shanghai, China, Shanghai, China

Meng Ji

2 Takeda Development Center Asian, Shanghai, China, Shanghai, China

Wenhan Jiang

2 Takeda Development Center Asian, Shanghai, China, Shanghai, China

Cassie Dong

3 Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA, Lexington, MA, USA, United States

Jun Zhu

1 Peking University Cancer Hospital and Institute,, Beijing, China, Department of Lymphoma, Beijing, China